Skip to main content
Freda Kreier on Muck Rack

Freda Kreier

Washington, D.C.
As seen in: The New York Times, Nature, The Atlantic, Ars Technica, Scientific American, Yale University, Flipboard, Live Science, Phys.org, The Mercury News and
She writes about science. MS in science communication UCSC. Tea addict. No, seriously. So much tea.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Freda

Contact Freda, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Breast cancer drug is effective for treatment-resistant uterine cancer

|
By Freda Kreier, Lisa Lock, Andrew Zinin Verified
| Medical Xpress Verified
Credit: Anna Tarazevich from Pexels Uterine cancer is the deadliest cancer of the female reproductive system. Currently, clinicians treat the disease by using a mix of surgery and chemotherapy. But not everyone responds to this line of treatment, and those who fail first-line therapies are often left without next steps. Research by the Yale School of Medicine (YSM) shows that a breast cancer drug could provide new options for people suffering from treatment-resistant uterine cancer.
Open in Who Shared Issue with article?

Brain's chemical brake hides a second power, and it could reshape how mental disorders are treated

|
By Freda Kreier, Sadie Harley, Andrew Zinin Verified
| Medical Xpress Verified
An important chemical messenger that typically inhibits brain activity might sometimes do the opposite, according to new Yale School of Medicine (YSM) research. One way that brain cells communicate is through chemical messengers called neurotransmitters. Most research indicates that the neurotransmitter GABA (gamma-aminobutyric acid) quiets brain signals, serving as the system's brakes. Now, a new study published in Neuron suggests that this story might not be so simple.
Open in Who Shared View Duplicates (3) Issue with article?

Breast Cancer Drug Is Effective for Treatment-Resistant Uterine Cancer

|
By Freda Kreier
| Yale University
A breast cancer drug could provide new options for people suffering from treatment-resistant uterine cancer, according to new Yale School of Medicine (YSM) research. Uterine cancer is the deadliest cancer of the female reproductive system. Currently, clinicians treat the disease by using a mix of surgery and chemotherapy. But not everyone responds to this line of treatment, and those who fail first-line therapies are often left without next steps.
Open in Who Shared Issue with article?
See all 377 licensed articles (391 Total)